Lipocine Inc. (LPCN) stock fell during pre-market trading. Here’s to know why?
Lipocine Inc. (NASDAQ: LPCN) stock declined by 1.55% at last close whereas the LPCN stock price plunged by 2.36% in the pre-market trading session. Lipocine is a clinical-stage biopharmaceutical business that uses its patented drug delivery technology to treat metabolic and endocrine diseases. >> 7 Top Picks for the Post-Pandemic Economy << What is happening? […]
What’s Driving The Lipocine Inc. (LPCN) Stock Higher Pre-Market Today?
Shares of biopharmaceutical company Lipocine Inc. (NASDAQ: LPCN) have been up trending in early hours trading today. As of 07:17 a.m. EST, the stock was up +9.79% to $1.57 with 1.16M shares changed hands. Get the hottest stocks to trade every day before the market opens 100% free. Click here now. What’s driving the stock? […]
